Page last updated: 2024-12-11

14,15-episulfide eicosatrienoic acid

Description

## 14,15-Episulfide Eicosatrienoic Acid (14,15-EpETE)

14,15-EpETE is a **sulfur-containing fatty acid** that is a **metabolite of arachidonic acid**. It's formed by the enzyme **cytochrome P450**, specifically the CYP2J2 isoform. This means it's a member of the **eicosanoid family**, which includes prostaglandins, leukotrienes, and thromboxanes, all involved in a variety of biological processes.

**What makes it special?**

* **Unique structure:** 14,15-EpETE features a **sulfur bridge** between carbons 14 and 15 of its eicosatrienoic acid backbone. This unique structure gives it distinct properties compared to other eicosanoids.
* **Biological activity:** 14,15-EpETE is known to have **anti-inflammatory**, **pro-resolving**, and **anti-tumor** effects. It also seems to be involved in **blood pressure regulation** and **vascular function**.

**Why is it important for research?**

1. **Potential therapeutic target:** Its diverse biological activity makes it an attractive target for developing new drugs for various diseases, including:
* **Inflammation:** 14,15-EpETE's anti-inflammatory properties could be harnessed for treating inflammatory conditions like rheumatoid arthritis or inflammatory bowel disease.
* **Cancer:** Its potential to inhibit tumor growth makes it an area of study for developing new cancer therapies.
* **Cardiovascular diseases:** Its role in blood pressure regulation and vascular function suggests its potential for treating hypertension and other cardiovascular issues.

2. **Understanding inflammatory pathways:** Studying the mechanisms of action of 14,15-EpETE can help researchers understand how the body controls inflammation and tissue repair, leading to more effective treatment strategies.

3. **Developing new analytical tools:** The unique structure of 14,15-EpETE requires specific analytical methods for detection and quantification. This research can lead to the development of new tools for studying this and other sulfur-containing lipids, which are often overlooked in conventional lipidomics analyses.

**Challenges:**

* **Limited understanding:** Despite its promising potential, our knowledge about 14,15-EpETE's detailed mechanisms of action and its role in various biological processes is still limited.
* **Lack of specific inhibitors:** Currently, there are no specific inhibitors for the enzymes responsible for 14,15-EpETE production, which hinders targeted research.

**Future Research:**

* **More in-depth studies** are needed to understand the specific roles of 14,15-EpETE in different cell types and tissues.
* **Development of specific inhibitors** to modulate its production and study its effects in vivo.
* **Clinical trials** to evaluate its therapeutic potential in human diseases.

Overall, 14,15-EpETE is a fascinating lipid with promising therapeutic potential. Further research is crucial to understand its full biological activity and pave the way for its translation into clinical applications.

14,15-episulfide eicosatrienoic acid: inhibits ionophore but not thrombin-induced platelet aggregation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6438816
MeSH IDM0184763

Synonyms (6)

Synonym
14,15-episulfide eicosatrienoic acid
(5e,8e,11e)-13-[(3s)-3-pentylthiiran-2-yl]trideca-5,8,11-trienoic acid
98893-66-4
14,15 epoxyeicosa-5(z)-enoic acid
14,15-cis-episulfide-eicosatrienoic acid
5,8,11-tridecatrienoic acid, 13-(3-pentylthiiranyl)-, (2alpha(5z,8z,11z),3alpha)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (12.50)18.2507
2000's7 (43.75)29.6817
2010's7 (43.75)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.03 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
chemdatabank.com